Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Obesity 1Neoplasms 1Motor Activity 1Diabetes Mellitus 1Cardiovascular Diseases 1

Interventions

Cyclophosphamide 910Carboplatin 788pembrolizumab 747Paclitaxel 744Bevacizumab 716Cisplatin 709Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 339Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Jogging × Clear all
NCT01953224 2018-08-01

STEP AND GO: A Study of Technology-based Exercise Promotion

The University of Texas Medical Branch, Galveston

Phase NA Completed
40 enrolled 12 charts
Other

Cardiovascular Diseases, Diabetes Mellitus, Motor Activity, Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡